The European Association for Haemophilia and Allied Disorders is inviting haemophilia
specialists to apply for two (2) posts on its Gene Therapy Working Group. The positions
are for a three-year term that would begin in February 2025.
If you are interested in applying, please send a short letter of motivation (maximum
300 words) outlining why you wish to be a part of the working group. Please also
include in the letter the following information:
- Full name
- Haemophilia Treatment Centre you are affiliated with
- Number of years working with people with haemophilia and allied bleeding
disorders - Number of years being involved in haemophilia gene therapy
Please send your letter to diana.carbonero@eahad.org no later than Friday 20
December 2024.
It will be considered carefully by the current Gene Therapy Working group members to select the applicants whose profile and motivations best fit with the working group’s current composition.
Please note that in order to be considered for a place on the Gene Therapy Working
Group, you must:
- be able to speak and read English at an intermediate or higher level
- be affiliated to a Haemophilia Treatment Centre.
EAHAD Gene Therapy Working Group membership offers an opportunity to be at the
forefront of providing critical information to health professionals and patients about the
practicality and safety of gene therapy. For more information on the working group,
please see the Terms of Reference.
Should you have any questions about the application process, please do not hesitate
to contact Diana Carbonero at diana.carbonero@eahad.org.